BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25006630)

  • 1. Impact of precontrast T10 relaxation times on dynamic contrast-enhanced MRI pharmacokinetic parameters: T10 mapping versus a fixed T10 reference value.
    Heye T; Boll DT; Reiner CS; Bashir MR; Dale BM; Merkle EM
    J Magn Reson Imaging; 2014 May; 39(5):1136-45. PubMed ID: 25006630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions.
    Heye T; Davenport MS; Horvath JJ; Feuerlein S; Breault SR; Bashir MR; Merkle EM; Boll DT
    Radiology; 2013 Mar; 266(3):801-11. PubMed ID: 23220897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced MRI: Study of inter-software accuracy and reproducibility using simulated and clinical data.
    Beuzit L; Eliat PA; Brun V; Ferré JC; Gandon Y; Bannier E; Saint-Jalmes H
    J Magn Reson Imaging; 2016 Jun; 43(6):1288-300. PubMed ID: 26687041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative dynamic contrast-enhanced MRI of pelvic and lumbar bone marrow: effect of age and marrow fat content on pharmacokinetic parameter values.
    Breault SR; Heye T; Bashir MR; Dale BM; Merkle EM; Reiner CS; Faridi KF; Gupta RT
    AJR Am J Roentgenol; 2013 Mar; 200(3):W297-303. PubMed ID: 23436875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter- and intra-rater reproducibility of quantitative dynamic contrast enhanced MRI using TWIST perfusion data in a uterine fibroid model.
    Davenport MS; Heye T; Dale BM; Horvath JJ; Breault SR; Feuerlein S; Bashir MR; Boll DT; Merkle EM
    J Magn Reson Imaging; 2013 Aug; 38(2):329-35. PubMed ID: 23239041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.
    Ginsburg SB; Taimen P; Merisaari H; Vainio P; Boström PJ; Aronen HJ; Jambor I; Madabhushi A
    J Magn Reson Imaging; 2016 Dec; 44(6):1405-1414. PubMed ID: 27285161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of dynamic contrast-enhanced MR imaging. Part II. Comparison of intra- and interobserver variability with manual region of interest placement versus semiautomatic lesion segmentation and histogram analysis.
    Heye T; Merkle EM; Reiner CS; Davenport MS; Horvath JJ; Feuerlein S; Breault SR; Gall P; Bashir MR; Dale BM; Kiraly AP; Boll DT
    Radiology; 2013 Mar; 266(3):812-21. PubMed ID: 23220891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of two-compartment-exchange-model analysis for dynamic contrast-enhanced mri incorporating bolus arrival time.
    Nadav G; Liberman G; Artzi M; Kiryati N; Bashat DB
    J Magn Reson Imaging; 2017 Jan; 45(1):237-249. PubMed ID: 27383624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast enhanced-MRI in head and neck cancer patients: variability of the precontrast longitudinal relaxation time (T10).
    Craciunescu O; Brizel D; Cleland E; Yoo D; Muradyan N; Carroll M; Barboriak D; MacFall J
    Med Phys; 2010 Jun; 37(6):2683-92. PubMed ID: 20632579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing MRI scan time in the computation of pharmacokinetic parameters (K(trans) ) in breast cancer diagnosis.
    Jena A; Mehta SB; Taneja S
    J Magn Reson Imaging; 2013 Sep; 38(3):573-9. PubMed ID: 23349046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis.
    El Khouli RH; Macura KJ; Kamel IR; Jacobs MA; Bluemke DA
    AJR Am J Roentgenol; 2011 Dec; 197(6):1498-505. PubMed ID: 22109308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Dynamic Contrast-Enhancement Parameters between Gadobutrol and Gadoterate Meglumine in Posttreatment Glioma: A Prospective Intraindividual Study.
    Park JE; Kim JY; Kim HS; Shim WH
    AJNR Am J Neuroradiol; 2020 Nov; 41(11):2041-2048. PubMed ID: 33060100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of analytical and numerical analysis of the reference region model for DCE-MRI.
    Lee J; Cárdenas-Rodríguez J; Pagel MD; Platt S; Kent M; Zhao Q
    Magn Reson Imaging; 2014 Sep; 32(7):845-53. PubMed ID: 24925838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study.
    Thomassin-Naggara I; Balvay D; Aubert E; Daraï E; Rouzier R; Cuenod CA; Bazot M
    Eur Radiol; 2012 Apr; 22(4):738-45. PubMed ID: 22105841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial input functions (AIFs) measured directly from arteries with low and standard doses of contrast agent, and AIFs derived from reference tissues.
    Wang S; Fan X; Medved M; Pineda FD; Yousuf A; Oto A; Karczmar GS
    Magn Reson Imaging; 2016 Feb; 34(2):197-203. PubMed ID: 26523650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous measurement of T
    Zhang J; Winters K; Reynaud O; Kim SG
    NMR Biomed; 2017 Sep; 30(9):. PubMed ID: 28544159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of the pharmacokinetic parameter ratios in DCE-MRI using the reference region model.
    Lee J; Platt S; Kent M; Zhao Q
    Magn Reson Imaging; 2012 Jan; 30(1):26-35. PubMed ID: 22071409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy and precision of quantitative DCE-MRI parameters: How should one estimate contrast concentration?
    Wake N; Chandarana H; Rusinek H; Fujimoto K; Moy L; Sodickson DK; Kim SG
    Magn Reson Imaging; 2018 Oct; 52():16-23. PubMed ID: 29777820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.